Analyst Reco. LeMaitre Vascular, Inc.

Equities

LMAT

US5255582018

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-18 pm EDT			5-day change	1st Jan Change
62.62 ^USD	-0.67%		-4.63%	+10.32%

Mar. 12	Lemaitre Vascular Insider Sold Shares Worth $309,684, According to a Recent SEC Filing	MT
Mar. 07	Lemaitre Vascular Insider Sold Shares Worth $344,925, According to a Recent SEC Filing	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Barrington Raises Price Target on LeMaitre Vascular to $69 From $66, Keeps Outperform Rating	Feb. 28	MT
JMP Securities Initiates LeMaitre Vascular With Market Outperform Rating, Price Target is $60	23-10-23	MT
Oppenheimer Initiates Coverage on LeMaitre Vascular With Outperform Rating, $70 Price Target	23-09-06	MT
Jefferies Downgrades LeMaitre Vascular to Hold From Buy, Adjusts Price Target to $67 From $63	23-08-03	MT
Barrington Raises Price Target on LeMaitre Vascular to $66 From $62, Maintains Outperform Rating	23-08-02	MT
Stifel Raises LeMaitre Vascular's Price Target to $60 From $48, Hold Rating Kept	23-05-03	MT
Jefferies Raises LeMaitre Vascular's Price Target to $63 From $57, Maintains Buy Rating	23-05-03	MT
Roth MKM Raises LeMaitre Vascular's Price Target to $54 From $48, Neutral Rating Kept	23-05-03	MT
Barrington Research Upgrades LeMaitre Vascular to Outperform From Market Perform	23-05-03	MT
Barrington Research Downgrades LeMaitre Vascular to Market Perform From Outperform	22-10-28	MT
Barrington Lowers LeMaitre Vascular's Price Target to $50 From $54, Maintains Outperform Rating	22-04-29	MT
Barrington Research Trims LeMaitre Vascular's Price Target to $54 From $62, Maintains Outperform Rating	22-02-25	MT
Barrington Adjusts Price Target on LeMaitre Vascular to $62 From $64, Maintains Outperform Rating	21-10-29	MT
LEMAITRE VASCULAR : Jefferies Initiates LeMaitre Vascular at Buy Rating With $70 Price Target	21-09-16	MT
LEMAITRE VASCULAR : Roth Capital Adjusts LeMaitre Vascular's Price Target to $58 from $55, Keeps Neutral Rating	21-08-03	MT
LEMAITRE VASCULAR : Barrington Adjusts Price Target on LeMaitre Vascular to $64 From $59, Maintains Outperform Rating	21-07-30	MT
LEMAITRE VASCULAR : Roth Capital Adjusts LeMaitre Vascular PT to $55 From $53, Maintains Neutral Rating	21-05-04	MT
LEMAITRE VASCULAR : Barrington Adjusts Price Target on LeMaitre Vascular to $59 From $49, Maintains Outperform Rating	21-04-30	MT
LEMAITRE VASCULAR : Barrington Adjusts LeMaitre Vascular PT to $49 From $47, Maintains Outperform Rating	21-02-26	MT
LEMAITRE VASCULAR : KeyBanc Starts LeMaitre Vascular at Sector Weight	21-02-12	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. LeMaitre Vascular, Inc.

Equities

LMAT

US5255582018

Analyst Reco.

Filters